Canada has the highest rate of multiple sclerosis (MS) in the world, with an estimated 100,000 Canadians living with the disease. More than 2.3 million people are affected worldwide and the progression of the disease is unique to each patient. While it is most often diagnosed in young adults aged 15 to 40, younger children and older adults can also be diagnosed with the disease.
Diagnosing MS continues to be challenging but treating MS is starting to change rapidly. Although there is no known cure today, our researchers and clinicians are on a pathway of discovery and innovation, paving the way forward to achieve the impossible.
The uOBMRI MS Group was founded in order to systematically research the underlying mechanisms of MS, unravel regeneration processes, develop new approaches for treatment and implement innovative rehabilitation processes at our partnering hospitals in Ottawa. With the belief that a collaborative approach is key, the group features members with a wide range of interests and expertise.
The Brain and Mind Research Institute is uniquely positioned to lead the world in the effort towards a cure for MS. We have a unique combination of strengths in biology, neuroscience, physics and mathematics, and expertise in brain circuitry and computational biology.